Total Payments
$760,788
2024 Payments
$116,230
Companies
35
Transactions
543
Medicare Patients
82
Medicare Billing
$7,918
Payment Breakdown by Category
Consulting$414,614 (54.5%)
Other$180,731 (23.8%)
Travel$94,932 (12.5%)
Research$61,425 (8.1%)
Food & Beverage$9,071 (1.2%)
Education$15.27 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $414,614 | 106 | 54.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $154,631 | 32 | 20.3% |
| Travel and Lodging | $94,932 | 110 | 12.5% |
| Unspecified | $61,425 | 75 | 8.1% |
| Honoraria | $26,100 | 8 | 3.4% |
| Food and Beverage | $9,071 | 211 | 1.2% |
| Education | $15.27 | 1 | 0.0% |
Payments by Type
General
$699,363
468 transactions
Research
$61,425
75 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $323,444 | 141 | $0 (2024) |
| PFIZER INC. | $87,631 | 59 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $84,572 | 25 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $61,380 | 62 | $0 (2024) |
| LEO Pharma AS | $32,925 | 10 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $28,176 | 37 | $0 (2024) |
| ABBVIE INC. | $23,864 | 41 | $0 (2024) |
| Incyte Corporation | $20,778 | 37 | $0 (2023) |
| Eli Lilly and Company | $18,666 | 13 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $13,358 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $116,230 | 116 | GENZYME CORPORATION ($37,678) |
| 2023 | $261,454 | 140 | GENZYME CORPORATION ($170,166) |
| 2022 | $151,208 | 89 | GENZYME CORPORATION ($90,159) |
| 2021 | $77,890 | 45 | PFIZER INC. ($26,570) |
| 2020 | $54,788 | 33 | GENZYME CORPORATION ($19,919) |
| 2019 | $46,615 | 31 | SANOFI-AVENTIS U.S. LLC ($38,106) |
| 2018 | $36,356 | 58 | Incyte Corporation ($20,685) |
| 2017 | $16,247 | 31 | Regeneron Healthcare Solutions, Inc. ($7,052) |
All Payment Transactions
543 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | LEO Pharma AS | — | Consulting Fee | Cash or cash equivalent | $6,335.00 | General |
| 12/16/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $7,425.00 | General |
| 12/16/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $1,687.50 | General |
| 12/13/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $242.90 | General |
| 12/13/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $26.80 | General |
| 12/13/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $20.00 | General |
| 12/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: Inflammation & Immunology | ||||||
| 12/05/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $690.05 | General |
| 12/05/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $136.02 | General |
| 12/05/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $43.04 | General |
| 12/05/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $25.04 | General |
| 12/05/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $14.99 | General |
| 12/04/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $232.45 | General |
| 12/04/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $154.49 | General |
| 12/04/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $84.99 | General |
| 12/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/31/2024 | PFIZER INC. | LITFULO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,650.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $9,090.00 | General |
| Category: Immunology | ||||||
| 10/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Immunology | ||||||
| 10/26/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $3,839.10 | General |
| Category: Immunology | ||||||
| 10/25/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $14,038.50 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: Pulmonology | ||||||
| 10/21/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $16.16 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| DUPIXENT CLINICAL DEVELOPMENT PROGRAM | Regeneron Pharmaceuticals, Inc. | $19,413 | 15 |
| ABROCITINIB CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $16,640 | 20 |
| A Randomized, Double Blind, Placebo-controlled, Multi-center, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Patients With Prurigo Nodularis Who Are Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable | GENZYME CORPORATION | $10,750 | 24 |
| A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO DEMONSTRATE THE EFFICACY AND LONG-TERM SAFETY OF DUPILUMAB IN ADULT PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS | Regeneron Pharmaceuticals, Inc. | $4,672 | 11 |
| CRISABOROLE CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $4,600 | 1 |
| RITLECITINIB CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $4,600 | 2 |
| A Randomized, Double Blind, Placebo-controlled, Multi-center, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Patients With Prurigo Nodularis Who Are Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable | SANOFI-AVENTIS U.S. LLC | $750.00 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 2 | 42 | 53 | $12,941 | $4,551 |
| 2020 | 2 | 40 | 44 | $10,792 | $3,368 |
Total Patients
82
Total Services
97
Medicare Billing
$7,918
Procedure Codes
4
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 30 | 41 | $9,668 | $3,643 | 37.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 12 | 12 | $3,273 | $907.70 | 27.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 20 | 24 | $5,472 | $1,821 | 33.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 20 | 20 | $5,320 | $1,547 | 29.1% |
About Dr. Brian Kim, MD
Dr. Brian Kim, MD is a Dermatology healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/17/2007. The National Provider Identifier (NPI) number assigned to this provider is 1336331826.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Kim, MD has received a total of $760,788 in payments from pharmaceutical and medical device companies, with $116,230 received in 2024. These payments were reported across 543 transactions from 35 companies. The most common payment nature is "Consulting Fee" ($414,614).
As a Medicare-enrolled provider, Kim has provided services to 82 Medicare beneficiaries, totaling 97 services with total Medicare billing of $7,918. Data is available for 2 years (2020–2021), covering 4 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Saint Louis, MO
- Active Since 08/17/2007
- Last Updated 11/12/2021
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1336331826
Products in Payments
- DUPIXENT (Biological) $284,864
- DUPIXENT (Drug) $38,170
- CIBINQO (Drug) $22,982
- EUCRISA (Drug) $19,085
- DUPIXENT DUPILUMAB INJECTION (Biological) $18,029
- Otezla (Drug) $4,616
- LITFULO (Drug) $3,650
- COSENTYX (Biological) $3,600
- RINVOQ (Biological) $3,064
- SKYRIZI (Biological) $675.00
- SKYRIZI (Drug) $675.00
- TALTZ (Drug) $260.90
- OFEV (Drug) $218.57
- Cimzia (Drug) $160.23
- Prolastin-C Liquid (Biological) $103.98
- VTAMA (Drug) $100.00
- ADBRY (Biological) $97.47
- JUBLIA (Drug) $89.00
- OPZELURA (Drug) $76.50
- COSENTYX (Drug) $70.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Saint Louis
Elaine Siegfried, Md, MD
Dermatology — Payments: $1.1M
Dermatology $1.1M
Dr. Craig Leonardi, M.d, M.D
Dermatology — Payments: $1.0M
Dermatology $1.0M
Dr. Mary Noel George, Md, MD
Dermatology — Payments: $498,600
Dermatology $498,600
Dee Glaser
Dermatology — Payments: $241,089
Dermatology $241,089
Jeffrey Reed, Md, MD
Dermatology — Payments: $188,305
Dermatology $188,305
Dr. Milan Anadkat, Md, MD
Dermatology — Payments: $155,718
Dermatology $155,718